New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
12:13 EDTELOSSyneron Medical recommend following FDA clearance at Maxim
Maxim recommends investors continue buying shares of Syneron Medical following the FDA clearance of UltraShape. Maxim says UltraShape expands the base of body shaping treatments that physicians may use with complimentary Syneron systems and it keeps a Buy rating on the stock with a $16 price target.
News For ELOS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 26, 2015
14:47 EDTELOSJames Flynn reports 5.37% passive stake in Syneron Medical
May 14, 2015
07:46 EDTELOSSyneron Medical weakness a buying opportunity, says Brean Capital
Subscribe for More Information
May 13, 2015
06:17 EDTELOSSyneron Medical reports Q1 non-GAAP EPS 2c, consensus 1c
Reports Q1 revenue $63.4M, consensus $62.08M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use